Latest filing published 14 Aug 2025 for AMEDISYS INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Denise M. Bohnert in Amedisys Inc, where the filings describe the role as senior executive. We count 15 filings; the first trade dates from 10 June 2021 and the latest from 14 August 2025.
No open-market purchase appears, only 1 sale worth €61k. Other entries cover 13 share grants.
The newest entry dates from 14 August 2025: a transaction, in Amedisys Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations